» Articles » PMID: 37735829

Clinical Features and Risk Factors of Post-COVID-19 Condition in Korea

Overview
Specialty Public Health
Date 2023 Sep 22
PMID 37735829
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Numerous studies have explored the causes and spread of outbreaks, yet there is a lack of research on post-coronavirus disease 2019 condition (PCC) in Korea. The goal of this study was to identify the various types of PCC and associated factors in discharged patients and to provide directions for the ongoing health management of confirmed patients.

Methods: A telephone survey was conducted among 680 coronavirus disease 2019 (COVID-19) patients diagnosed between July 7, 2021 and August 26, 2021, in Dangjin, Chungnam, Korea. A descriptive analysis of characteristics, univariate analysis, and regression were performed using data from basic epidemiological surveys conducted at the time of diagnosis and post-discharge questionnaires.

Results: Of the 585 patients who responded, 159 (27.2%) developed PCC. Of the 211 patients with no initial symptoms, 27 (12.8%) developed PCC, versus 132 (35.3%) of the 374 patients with initial symptoms. Among the initial symptoms, fever or chills, cough or sputum, loss of smell, and sore throat were associated with PCC. Compared to patients with less than 10 days of hospitalization, those with a hospitalization period of 21 days to 30 days (odds ratio [OR], 2.3; 95% confidence interval [CI], 1.0 to 5.2) and 31 days or more (OR, 5.8; 95% CI, 1.9 to 18.1) had a higher risk of PCC.

Conclusions: More than a quarter of COVID-19 patients, including those who had no initial symptoms, experienced PCC in Korea. People with the initial symptoms of fever, chills, and respiratory symptoms and those who had prolonged hospital stays had a high risk of PCC.

References
1.
Zhang X, Wang F, Shen Y, Zhang X, Cen Y, Wang B . Symptoms and Health Outcomes Among Survivors of COVID-19 Infection 1 Year After Discharge From Hospitals in Wuhan, China. JAMA Netw Open. 2021; 4(9):e2127403. PMC: 8482055. DOI: 10.1001/jamanetworkopen.2021.27403. View

2.
Peghin M, Palese A, Venturini M, De Martino M, Gerussi V, Graziano E . Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clin Microbiol Infect. 2021; 27(10):1507-1513. PMC: 8180450. DOI: 10.1016/j.cmi.2021.05.033. View

3.
Baruch J, Zahra C, Cardona T, Melillo T . National long COVID impact and risk factors. Public Health. 2022; 213:177-180. PMC: 9683693. DOI: 10.1016/j.puhe.2022.09.021. View

4.
Chang M, Park Y, Kim B, Park D . Risk factors for disease progression in COVID-19 patients. BMC Infect Dis. 2020; 20(1):445. PMC: 7309210. DOI: 10.1186/s12879-020-05144-x. View

5.
Castanares-Zapatero D, Chalon P, Kohn L, Dauvrin M, Detollenaere J, Maertens de Noordhout C . Pathophysiology and mechanism of long COVID: a comprehensive review. Ann Med. 2022; 54(1):1473-1487. PMC: 9132392. DOI: 10.1080/07853890.2022.2076901. View